BioCentury
ARTICLE | Clinical News

Provir: Started a Phase II trial

January 31, 1994 8:00 AM UTC

Shaman Pharmaceuticals Inc. (SHMN), South San Francisco Product: Provir, oral antiviral compound Indication: Respiratory syncytial virus (RSV) Status: Started a Phase II trial in hospitalized children...